Zhejiang Wecome Pharmaceutical Company Limited (300878.SZ)
CNY 14.88
(0.4%)
CNY 14.88
(0.4%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 153.78 Million CNY | 32.45% |
| 2022 | 116.11 Million CNY | -10.33% |
| 2021 | 129.49 Million CNY | 57.33% |
| 2020 | 82.3 Million CNY | 36.13% |
| 2019 | 60.45 Million CNY | -17.48% |
| 2018 | 73.26 Million CNY | -1.76% |
| 2017 | 74.57 Million CNY | 57.3% |
| 2016 | 47.41 Million CNY | 19.53% |
| 2015 | 39.66 Million CNY | 108.49% |
| 2014 | 19.02 Million CNY | 19.52% |
| 2013 | 15.91 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 135.21 Million CNY | 9.62% |
| 2024 Q1 | 123.35 Million CNY | -19.79% |
| 2024 Q3 | 109.06 Million CNY | -19.34% |
| 2023 Q1 | 121.77 Million CNY | 4.88% |
| 2023 FY | 153.78 Million CNY | 32.45% |
| 2023 Q4 | 153.78 Million CNY | -3.2% |
| 2023 Q2 | 137.09 Million CNY | 12.58% |
| 2023 Q3 | 158.87 Million CNY | 15.88% |
| 2022 Q4 | 116.11 Million CNY | -42.29% |
| 2022 FY | 116.11 Million CNY | -10.33% |
| 2022 Q3 | 201.2 Million CNY | 79.76% |
| 2022 Q1 | 125.13 Million CNY | -3.36% |
| 2022 Q2 | 111.92 Million CNY | -10.56% |
| 2021 Q3 | 99.78 Million CNY | 4.8% |
| 2021 FY | 129.49 Million CNY | 57.33% |
| 2021 Q4 | 129.49 Million CNY | 29.77% |
| 2021 Q2 | 95.21 Million CNY | 6.3% |
| 2021 Q1 | 89.57 Million CNY | 8.83% |
| 2020 FY | 82.3 Million CNY | 36.13% |
| 2020 Q4 | 82.3 Million CNY | 37.11% |
| 2020 Q2 | 63.78 Million CNY | 0.0% |
| 2020 Q1 | - CNY | -100.0% |
| 2020 Q3 | 60.02 Million CNY | -5.89% |
| 2019 Q4 | 60.45 Million CNY | 0.0% |
| 2019 FY | 60.45 Million CNY | -17.48% |
| 2019 Q1 | - CNY | 0.0% |
| 2018 FY | 73.26 Million CNY | -1.76% |
| 2017 FY | 74.57 Million CNY | 57.3% |
| 2016 FY | 47.41 Million CNY | 19.53% |
| 2015 FY | 39.66 Million CNY | 108.49% |
| 2014 FY | 19.02 Million CNY | 19.52% |
| 2013 FY | 15.91 Million CNY | 0.0% |